2016
DOI: 10.1016/j.jamda.2016.07.029
|View full text |Cite
|
Sign up to set email alerts
|

Sarcopenia Screened With SARC-F Questionnaire Is Associated With Quality of Life and 4-Year Mortality

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
51
0
2

Year Published

2017
2017
2023
2023

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 87 publications
(65 citation statements)
references
References 24 publications
5
51
0
2
Order By: Relevance
“…In our study, we found that both sarcopenia and frailty were significantly more common in PD patients compared with the general elderly population. The prevalence rates of sarcopenia and frailty in our general population-based sample were within previously reported ranges, contributing to the validity of the screening tools used [4,[6][7][8][9][10][11][12]. The prevalence rates of sarcopenia and frailty were slightly lower in the community-based PD cohort compared to the PD cohort recruited in the tertiary center.…”
Section: Discussionsupporting
confidence: 76%
See 3 more Smart Citations
“…In our study, we found that both sarcopenia and frailty were significantly more common in PD patients compared with the general elderly population. The prevalence rates of sarcopenia and frailty in our general population-based sample were within previously reported ranges, contributing to the validity of the screening tools used [4,[6][7][8][9][10][11][12]. The prevalence rates of sarcopenia and frailty were slightly lower in the community-based PD cohort compared to the PD cohort recruited in the tertiary center.…”
Section: Discussionsupporting
confidence: 76%
“…While several tools have been used in the past to identify sarcopenia and frailty, there is no gold standard to diagnose these syndromes [7,18]. In the present study, we decided to use two simple and quick screening tools for their identification due to the population-based nature of the Bruneck Study.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…1), we finally included 14 studies assessing the difference in health care costs between individuals with or without sarcopenia [10][11][12][13][14][15][16][17][18][19][20][21][22][23]. Sixteen studies were rejected because of duplicate (n = 2) [11,20], wrong outcomes (n = 13) [24][25][26][27][28][29][30][31][32][33][34][35][36] or wrong exposure factor (n = 1) [38].…”
Section: Literature Searchmentioning
confidence: 99%